Christopher R. Denz

Expression of a novel cardiac-specific tropomyosin isoform in humans

Christopher R. Denz, Aruna Narshi, Robert W. Zajdel et al. · Biochemical and Biophysical Research Communications · 2004 · 67 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +5

Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling <i>in Vivo</i>

James J. Dowling, Marat Alimzhanov, Larry Bao et al. · ACS Medicinal Chemistry Letters · 2016 · 54 citations · Full text

Molecular Pharmacology, Ck2 Kinase Activity, Signal Transduction +14

Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

James J. Dowling, Marat Alimzhanov, Larry Bao et al. · ACS Medicinal Chemistry Letters · 2013 · 53 citations · Full text

Ck2 Kinase, Medicinal Chemistry, Drug Target +14

Structure‐Based Design of Selective Noncovalent CDK12 Inhibitors

Jeffrey W. Johannes, Christopher R. Denz, Nancy Su et al. · ChemMedChem · 2017 · 52 citations

Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization

James J. Dowling, Claudio Chuaqui, Timothy Pontz et al. · ACS Medicinal Chemistry Letters · 2012 · 47 citations · Full text

Combinatorial Chemistry, Drug Target, Structure-guided Hybridization +18